FDA Inspection 1261655 — Navpreet Kaur, M.D.
The FDA completed an inspection of Navpreet Kaur, M.D. on Feb 7, 2025 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 7, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional details
Clinical Investigator (CI)